Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Rocco, N, Montagna, G, Di Micco, R, Benson, J, Criscitiello, C, Chen, L, Di Pace, B, Esgueva Colmenarejo, AJ, Harder, Y, Karakatsanis, A, Maglia, A, Mele, M, Nafissi, N, Ferreira, PS, Taher, W, Tejerina, A, Vinci, A, Nava, M & Catanuto, G 2021, 'The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives', Oncologist, bind 26, nr. 1, s. e66-e77. https://doi.org/10.1002/onco.13560

APA

Rocco, N., Montagna, G., Di Micco, R., Benson, J., Criscitiello, C., Chen, L., Di Pace, B., Esgueva Colmenarejo, A. J., Harder, Y., Karakatsanis, A., Maglia, A., Mele, M., Nafissi, N., Ferreira, P. S., Taher, W., Tejerina, A., Vinci, A., Nava, M., & Catanuto, G. (2021). The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives. Oncologist, 26(1), e66-e77. https://doi.org/10.1002/onco.13560

CBE

Rocco N, Montagna G, Di Micco R, Benson J, Criscitiello C, Chen L, Di Pace B, Esgueva Colmenarejo AJ, Harder Y, Karakatsanis A, Maglia A, Mele M, Nafissi N, Ferreira PS, Taher W, Tejerina A, Vinci A, Nava M, Catanuto G. 2021. The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives. Oncologist. 26(1):e66-e77. https://doi.org/10.1002/onco.13560

MLA

Vancouver

Author

Rocco, Nicola ; Montagna, Giacomo ; Di Micco, Rosa ; Benson, John ; Criscitiello, Carmen ; Chen, Li ; Di Pace, Bruno ; Esgueva Colmenarejo, Antonio Jesus ; Harder, Yves ; Karakatsanis, Andreas ; Maglia, Anna ; Mele, Marco ; Nafissi, Nahid ; Ferreira, Pedro Santos ; Taher, Wafa ; Tejerina, Antonio ; Vinci, Alessio ; Nava, Maurizio ; Catanuto, Giuseppe. / The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer : Global Trends and Future Perspectives. I: Oncologist. 2021 ; Bind 26, Nr. 1. s. e66-e77.

Bibtex

@article{c55c2f8efcc44c47be99f1c1d0e72696,
title = "The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives",
abstract = "Introduction: The rapid spread of COVID-19 across the globe is forcing surgical oncologists to change their daily practice. We sought to evaluate how breast surgeons are adapting their surgical activity to limit viral spread and spare hospital resources. Methods: A panel of 12 breast surgeons from the most affected regions of the world convened a virtual meeting on April 7, 2020, to discuss the changes in their local surgical practice during the COVID-19 pandemic. Similarly, a Web-based poll based was created to evaluate changes in surgical practice among breast surgeons from several countries. Results: The virtual meeting showed that distinct countries and regions were experiencing different phases of the pandemic. Surgical priority was given to patients with aggressive disease not candidate for primary systemic therapy, those with progressive disease under neoadjuvant systemic therapy, and patients who have finished neoadjuvant therapy. One hundred breast surgeons filled out the poll. The trend showed reductions in operating room schedules, indications for surgery, and consultations, with an increasingly restrictive approach to elective surgery with worsening of the pandemic. Conclusion: The COVID-19 emergency should not compromise treatment of a potentially lethal disease such as breast cancer. Our results reveal that physicians are instinctively reluctant to abandon conventional standards of care when possible. However, as the situation deteriorates, alternative strategies of de-escalation are being adopted. Implications for Practice: This study aimed to characterize how the COVID-19 pandemic is affecting breast cancer surgery and which strategies are being adopted to cope with the situation.",
keywords = "Alternatives to surgery, Breast cancer surgery, COVID-19, Surgical priorities, Triage, Communicable Disease Control/organization & administration, Breast Neoplasms/pathology, Practice Patterns, Physicians'/economics, Surveys and Questionnaires/statistics & numerical data, Humans, Operating Rooms/economics, Neoadjuvant Therapy/statistics & numerical data, Surgeons/statistics & numerical data, Pandemics/prevention & control, Patient Selection, Global Burden of Disease, COVID-19/epidemiology, Female, Elective Surgical Procedures/standards, Health Care Rationing/standards, Time-to-Treatment, SARS-CoV-2/pathogenicity, Disease Progression, Referral and Consultation/statistics & numerical data, Appointments and Schedules, Personnel Staffing and Scheduling/economics, Mastectomy/economics",
author = "Nicola Rocco and Giacomo Montagna and {Di Micco}, Rosa and John Benson and Carmen Criscitiello and Li Chen and {Di Pace}, Bruno and {Esgueva Colmenarejo}, {Antonio Jesus} and Yves Harder and Andreas Karakatsanis and Anna Maglia and Marco Mele and Nahid Nafissi and Ferreira, {Pedro Santos} and Wafa Taher and Antonio Tejerina and Alessio Vinci and Maurizio Nava and Giuseppe Catanuto",
note = "Publisher Copyright: {\textcopyright} 2020 AlphaMed Press Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = jan,
doi = "10.1002/onco.13560",
language = "English",
volume = "26",
pages = "e66--e77",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press, Inc",
number = "1",

}

RIS

TY - JOUR

T1 - The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer

T2 - Global Trends and Future Perspectives

AU - Rocco, Nicola

AU - Montagna, Giacomo

AU - Di Micco, Rosa

AU - Benson, John

AU - Criscitiello, Carmen

AU - Chen, Li

AU - Di Pace, Bruno

AU - Esgueva Colmenarejo, Antonio Jesus

AU - Harder, Yves

AU - Karakatsanis, Andreas

AU - Maglia, Anna

AU - Mele, Marco

AU - Nafissi, Nahid

AU - Ferreira, Pedro Santos

AU - Taher, Wafa

AU - Tejerina, Antonio

AU - Vinci, Alessio

AU - Nava, Maurizio

AU - Catanuto, Giuseppe

N1 - Publisher Copyright: © 2020 AlphaMed Press Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/1

Y1 - 2021/1

N2 - Introduction: The rapid spread of COVID-19 across the globe is forcing surgical oncologists to change their daily practice. We sought to evaluate how breast surgeons are adapting their surgical activity to limit viral spread and spare hospital resources. Methods: A panel of 12 breast surgeons from the most affected regions of the world convened a virtual meeting on April 7, 2020, to discuss the changes in their local surgical practice during the COVID-19 pandemic. Similarly, a Web-based poll based was created to evaluate changes in surgical practice among breast surgeons from several countries. Results: The virtual meeting showed that distinct countries and regions were experiencing different phases of the pandemic. Surgical priority was given to patients with aggressive disease not candidate for primary systemic therapy, those with progressive disease under neoadjuvant systemic therapy, and patients who have finished neoadjuvant therapy. One hundred breast surgeons filled out the poll. The trend showed reductions in operating room schedules, indications for surgery, and consultations, with an increasingly restrictive approach to elective surgery with worsening of the pandemic. Conclusion: The COVID-19 emergency should not compromise treatment of a potentially lethal disease such as breast cancer. Our results reveal that physicians are instinctively reluctant to abandon conventional standards of care when possible. However, as the situation deteriorates, alternative strategies of de-escalation are being adopted. Implications for Practice: This study aimed to characterize how the COVID-19 pandemic is affecting breast cancer surgery and which strategies are being adopted to cope with the situation.

AB - Introduction: The rapid spread of COVID-19 across the globe is forcing surgical oncologists to change their daily practice. We sought to evaluate how breast surgeons are adapting their surgical activity to limit viral spread and spare hospital resources. Methods: A panel of 12 breast surgeons from the most affected regions of the world convened a virtual meeting on April 7, 2020, to discuss the changes in their local surgical practice during the COVID-19 pandemic. Similarly, a Web-based poll based was created to evaluate changes in surgical practice among breast surgeons from several countries. Results: The virtual meeting showed that distinct countries and regions were experiencing different phases of the pandemic. Surgical priority was given to patients with aggressive disease not candidate for primary systemic therapy, those with progressive disease under neoadjuvant systemic therapy, and patients who have finished neoadjuvant therapy. One hundred breast surgeons filled out the poll. The trend showed reductions in operating room schedules, indications for surgery, and consultations, with an increasingly restrictive approach to elective surgery with worsening of the pandemic. Conclusion: The COVID-19 emergency should not compromise treatment of a potentially lethal disease such as breast cancer. Our results reveal that physicians are instinctively reluctant to abandon conventional standards of care when possible. However, as the situation deteriorates, alternative strategies of de-escalation are being adopted. Implications for Practice: This study aimed to characterize how the COVID-19 pandemic is affecting breast cancer surgery and which strategies are being adopted to cope with the situation.

KW - Alternatives to surgery

KW - Breast cancer surgery

KW - COVID-19

KW - Surgical priorities

KW - Triage

KW - Communicable Disease Control/organization & administration

KW - Breast Neoplasms/pathology

KW - Practice Patterns, Physicians'/economics

KW - Surveys and Questionnaires/statistics & numerical data

KW - Humans

KW - Operating Rooms/economics

KW - Neoadjuvant Therapy/statistics & numerical data

KW - Surgeons/statistics & numerical data

KW - Pandemics/prevention & control

KW - Patient Selection

KW - Global Burden of Disease

KW - COVID-19/epidemiology

KW - Female

KW - Elective Surgical Procedures/standards

KW - Health Care Rationing/standards

KW - Time-to-Treatment

KW - SARS-CoV-2/pathogenicity

KW - Disease Progression

KW - Referral and Consultation/statistics & numerical data

KW - Appointments and Schedules

KW - Personnel Staffing and Scheduling/economics

KW - Mastectomy/economics

UR - http://www.scopus.com/inward/record.url?scp=85096708312&partnerID=8YFLogxK

U2 - 10.1002/onco.13560

DO - 10.1002/onco.13560

M3 - Journal article

C2 - 33044007

AN - SCOPUS:85096708312

VL - 26

SP - e66-e77

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 1

ER -

ID: 66209652